Suppr超能文献

基于 16S rRNA 的方法评估果聚糖、益生元和膳食纤维对人类肠道微生物组的影响:综述。

Effect of fructans, prebiotics and fibres on the human gut microbiome assessed by 16S rRNA-based approaches: a review.

机构信息

Division of Nutritional Sciences, University of Illinois at Urbana-Champaign,1207 W. Gregory Drive, Urbana, IL 61801, USA.

Laboratory of Microbiology, Wageningen University, Stippeneng 4, 6708 WE, Wageningen, the Netherlands.

出版信息

Benef Microbes. 2020 Mar 27;11(2):101-129. doi: 10.3920/BM2019.0082. Epub 2020 Feb 19.

Abstract

The inherent and diverse capacity of dietary fibres, nondigestible oligosaccharides (NDOs) and prebiotics to modify the gut microbiota and markedly influence health status of the host has attracted rising interest. Research and collective initiatives to determine the composition and diversity of the human gut microbiota have increased over the past decade due to great advances in high-throughput technologies, particularly the 16S ribosomal RNA (rRNA) sequencing. Here we reviewed the application of 16S rRNA-based molecular technologies, both community wide (sequencing and phylogenetic microarrays) and targeted methodologies (quantitative PCR, fluorescent hybridisation) to study the effect of chicory inulin-type fructans, NDOs and specific added fibres, such as resistant starches, on the human intestinal microbiota. Overall, such technologies facilitated the monitoring of microbiota shifts due to prebiotic/fibre consumption, though there are limited community-wide sequencing studies so far. Molecular studies confirmed the selective bifidogenic effect of fructans and galactooligosaccharides (GOS) in human intervention studies. Fructans only occasionally decreased relative abundance of or stimulated other groups. The sequencing studies for various resistant starches, polydextrose and beta-glucan showed broader effects with more and different types of gut microbial species being enhanced, often including phylotypes of . There was substantial variation in terms of magnitude of response and in individual responses to a specific fibre or NDO which may be due to numerous factors, such as initial presence and relative abundance of a microbial type, diet, genetics of the host, and intervention parameters, such as intervention duration and fibre dose. The field will clearly benefit from a more systematic approach that will support defining the impact of prebiotics and fibres on the gut microbiome, identify biomarkers that link gut microbes to health, and address the personalised response of an individual's microbiota to prebiotics and dietary fibres.

摘要

膳食纤维、不可消化的低聚糖(NDO)和益生元具有内在的和多样化的能力,可以改变肠道微生物群,并显著影响宿主的健康状况,这引起了人们越来越多的兴趣。由于高通量技术,特别是 16S 核糖体 RNA(rRNA)测序技术的巨大进步,过去十年中,研究和集体倡议来确定人类肠道微生物群的组成和多样性的工作有所增加。在这里,我们综述了基于 16S rRNA 的分子技术在研究菊苣菊糖型果聚糖、NDO 和特定添加纤维(如抗性淀粉)对人类肠道微生物群的影响中的应用,这些技术包括广泛的群落(测序和系统发育微阵列)和靶向方法(定量 PCR、荧光杂交)。总的来说,这些技术有助于监测由于益生元/纤维消耗而导致的微生物群变化,但到目前为止,还没有广泛的群落测序研究。分子研究证实了在人体干预研究中,果聚糖和半乳糖寡糖(GOS)具有选择性双歧杆菌作用。果聚糖偶尔会降低或刺激其他菌群的相对丰度。各种抗性淀粉、聚右旋糖和β-葡聚糖的分子研究显示出更广泛的影响,更多不同类型的肠道微生物物种得到增强,通常包括 的菌群。由于许多因素,例如微生物类型的初始存在和相对丰度、饮食、宿主的遗传,以及干预参数,如干预持续时间和纤维剂量,对特定纤维或 NDO 的反应幅度和个体反应存在很大差异。该领域显然将受益于一种更系统的方法,该方法将支持定义益生元和纤维对肠道微生物组的影响,确定将肠道微生物与健康联系起来的生物标志物,并解决个体肠道微生物对益生元和膳食纤维的个性化反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验